Scottsdale-based CND Life Sciences raises $4.5M in seed funding

Scottsdale-based CND Life Sciences recently closed on a $4.5 million seed funding round to further accelerate commercialization of its test to detect neurodegenerative diseases.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.